Bromocriptine
Back to searchMolecule Structure
Scientific Name
Bromocriptine
Description of the Drug
Bromocriptine is a dopamine D2 receptor agonist used for the treatment of galactorrhea due to hyperprolactinemia and other prolactin-related conditions, as well as in early Parkinsonian Syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01200
http://www.drugbank.ca/drugs/DB01200
Brand Name(s)
Parlodel
Company Owner(s)
Padagis Us Llc, Veroscience Llc, Sandoz Inc, Validus Pharmaceuticals Llc, Lek Pharmaceutical And Chemical Co Dd, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
D2-like dopamine receptor | PROTEIN FAMILY | AGONIST | CHEMBL2331075 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL25297 | |||
PharmGKB | PA448671 | |||
Human Metabolome Database | HMDB0015331 | |||
DrugBank | DB01200 | |||
PubChem: Thomson Pharma | 14765834 | 14765835 | ||
PubChem | 31101 | |||
NMRShiftDB | 60027642 | |||
LINCS | LSM-6550 | |||
Nikkaji | J16.988I | |||
PDBe | 08Y | |||
BindingDB | 81993 | |||
EPA CompTox Dashboard | DTXSID1022687 | |||
DrugCentral | 403 | |||
Metabolights | MTBLC3181 | |||
Brenda | 147619 | 147312 | ||
ChemicalBook | CB6136426 | |||
Guide to Pharmacology | 35 | |||
rxnorm | CYCLOSET | BROMOCRIPTINE | BROMOCRIPTINE MESYLATE | PARLODEL |
KEGG Ligand | C06856 | |||
ChEBI | 3181 | |||
ZINC | ZINC000053683151 |